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G. Eiras. J. Fung. and K.A. Porter 
I N doing liver transplantation. it is important to know the 
effect of immunosuppressive agents on hepatic regen-
eration. In many such patients. livers are transplanted that 
are not the ideal size for a particular recipient. Accommo-
dation of these organs to recipient size depends on poorly 
understood growth homeostasis which conceivably could 
be altered by the immunosuppressive agents. In fact. it has 
been reported that the regeneration response is inhibited 
by azathioprine and adrenal cortical steroids. 1.1 
CvA AND REGENERATION 
Largely because of such concerns. Makowka et al 3 tested 
hepatic generation after partial hepatectomy in rats treated 
with eyA and reported that the regeneration response was 
actually greater than normal. This finding has been con-
firmed by several investigatorsK4~ 
FK 506 AND REGENERATION 
More recently. we have demonstrated an even more 
dramatic augmentation of hepatic regeneration by FK 506. 
CyA and FK 506 have completely different molecular 
structures (Fig I). but they have in common the relatively 
specific inhibition of the T cell component of the immune 
system. 7•S Because of this similar mechanism. we have 
suggested that hepatic regeneration may be subject to 
immune modulation_ b 
The Immune modulation hypothesis was supported by 
the data summanzed in Fig 2. In essence. the increase In 
DNA and mitotic activity which is characteristic of a 70% 
hepatic resection in rats was increased significantly with 
CyA and nearly doubled when FK 506 was administered 
for 3 days preoperatively and for a final time just after 
completing the hepatic resection. 
IN VITRO MECHANISMS 
What was the explanation for these curious results? The 
first step was to establish pure hepatocyte cultures~ and to 
determine if the resttng rate of mitoses was altered by the 
direct addition of Cy A or FK 506 to the medium. A wide 
range of doses of both drugs was completely without effect 
(Fig 3). 
Hepatocyte cultures were now used for additional ex-
penments under two different conditions that are known to 
increase the basal rate of mitoses. In the first expenment. 
epidermal growth factor was added to the hepatocyte 
culture which. as expected. lo increased the basal mitotic 
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Fig 1. Structural formulas of FK 506 and CyA. 
rate approximately 10-fold. The addition of CyA and FK 
506 had no further effect (Fig 3). 
In the second experiment. normal rat serum. which in 
tissue culture systems is mitogenic in low doses.\! was 
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Fig 2. r3H)-lhymidlne Incorporation and percentage of mitosIs in 
normal and 70% hepatectomized rats treated or not treated with 
FK 506 and CyA. Control and immunosuppressive drug-treated 
ammals were given Intramuscular Inlectlons of vehicle and CyA 
and FK 506, 1 mg/kg body weight. respectively. for 3 days before 
surgery and again lust atter completing hepatic resection. The 
values represented by the bars are the means from at least 15 rats 
== SD. 'Signlflcantly different from 70"10 hepatectomized rats (P< 
0.05). "Significantly different from 70"10 hepatectomized rats (P < 
0.01) and CyA-treated 70% hepatectomized rats (P < 0.05). 
added to the hepatocyte culture in graded quantities (Table 
I). The expected increase in mitoses was seen at first with 
an inhibition of this effect as larger volumes of normal rat 
serum were added (Table I). As in the first experiment. 
there was no augmentation effect with Cy A on FK 506. 
From this we concluded that neither CyA nor FK 506 
had a direct effect on hepatocyte mitoses. no matter 
whether the mitotic index was at a resting or heightened 
level at the time of addition of the drug to the medium. 
In contrast. the serum from animals treated for 4 days 
with therapeutic doses of Cy A and FK 506 had a pro-
nounced effect on hepatocyte cultures !Table I). These 
sera caused an increase in mitosis far exceeding that seen 
with comparable amounts of normal rat serum. The stim-
ulatory potency of the rat serum was greater if the serum 
donors were treated with FK 506 than if therapy was with 
eyA. 
ARE THESE GROWTH EFFECTS LIVER SPECIFIC? 
We questioned whether eyA and FK 506 altered the 
regeneration of other organ systems. To test this possibil-
Ity. DNA synthesis was measured in kidneys before and 
after nght nephrectomy. The basal level of DN A synthesis 
was essentially doubled in the contralateral kidney after 
right nephrectomy. but this was not further increased by 
the treatment With FK 506 that enhanced liver regenera-
tion (Table 2l. 
With resection of 50% of the small bowel. DNA synthe-
sis in the residual small bowel tripled. as has been de-
scnbed by others. II This powerful regeneration response 
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Fig 3. Effect of different doses of FK 506 and CyA on DNA 
syntheSIS in hepatocytes cultured in presence or not of epidermal 
growth factor (EGF). (Solid line, FK 506; broken line. CyA.) 
Hepatocytes were ,solated as preViously descnbed. a They were 
plated at a denSity of 1.5 x 105 cell/dish in 1.5 ml of minimum 
essential medium (MEM) + 5% felal calf serum + Insulin (10- 7 
moVL) and maintained at 37"C in a 5% CO2 atmosphere. Following 
a 3-hour attachment period. the medium was substituted with 1.5 
ml of fresh MEM and insulin with or without EGF (10 mg/ml). DNA 
content and (JH!-thymldine incorporation were determined as 
previously descnbed.6 When added to the incubation medium, FK 
506 and CyA vehicles were used a.t concentrations <0.2 ~mlK 
which did not affect hepatocyte proliferation (data not shown). The 
values reported represent the means of five expenments :t SD. 
was neither increased or decreased by treatment of these 
animals with FK 506 (Table 2). 
DISCUSSION AND CONCLUSIONS 
These observations could have a deeper biologic signifi-
canCe than those practical questions which prompted us to 
begin these studies. It remains possible that the immune 
system has a "braking" effect on hepatocyte cell mitosis. 
and that this is unmasked by powerful T cell-specific 
immunosuppression. From the work presented here. it is 
probable that this control is at least relatively liver-spe-
cific: at least it could not be identified in regenerating 
kidney or intestine. The fact that eyA and FK 506 did not 
have a direct action on cultured hepatocytes. but that the 
serum of immunosuppressed animals was stimulatory to 
these same cell cultures. suggests that some CIrculating 
substance is induced by eyA and FK 506. eyA and FK 
506 act by inhibiting IL2 production and binding. 7•8 It is 
conceivable that by inhibition of this second signal. both 
drugs could interrupt the secretton of liver regulatory 
factors. either by as yet unknown immune mechanisms or. 
possibly. by pathways that are not directly connected with 
the immune system. 
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Table 1. Ett.ct of CyA and FK 506' on Hepatocyte DNA Synthesl. 
Addition to the InCuOIIIIOn 
[ltil-Thyrmdme IncrlIUOnIbOn ICIlITI " 1(),"/mg DNA) 
GrouoNo. MedIum (MEM + insulin) .,. Serum 5 10 20 30 4{) 
1 NRS 110 = 15 88 = 9 71 = 14 53 = 5 63 = 7 
2 NRS + eyA 92 = 10 82 = 10 56 = 8 57 = 7 38 = 7 
3 NRS + FK 506 86: 11 83: 4 59 = 9 52 = 6 36: 7 
4 Vehicle-trealed rat serum 130: 18 124: 10 106: 6 82: 10 68: 8 
5 CyA-trealed rat serum 140: 7 167 = 11' 196 = 12' 170 = 11' 114:!: 10' 
6 FK 5CJ6.treated rat serum 154: 16 306: 28' 286 = 26' 244:!: 17' 225 = 15' 
Note: Cultunt condrIICInIera the __ u Clelcnbed III Fig 3. the only dl1l __ betng lllat rat 8tIIUI1I wu UI8CI as mllOglll'llllstead of eOldennal growth tactor. In groups 
2 and 3. the 00 iC8I 118101 In the InCUII8IICIn mecium 01 FK 506 and CyA ve/llClel wu <0.2 mglmt: tIllS conc:entra1lOn did not alfeel I\el)8tocyte proalerabOn (data not 
Shown,. The .,..mllla useclII'I9roupt 4-6100f0'II(Ie8tllUl1l were IrNIad u desc:nb8din Fig 2,the dIfference betng lllat on the tounn day. they only ~ the lutll1JeC11On 
and the blood wu drtIWn 2 houri .... The YIIIues reparIad are the me.. of live exP8fllT18n1s : SO. 
AbbnMeIlOnl: MEM. mlllll'llUln __ medtum: NRS. nonnat rat IIBIUm. 
'SlgniflCantly di"-"t !rom group no. 4 (P < 0.05). 
tSlgnihcantly different !rom 9IOUPI no. 4 (P < 0.02) and 5 (P < 0.01). 
Table 2. ('H]-ThymldlnelnCOllMX1ltlon In Kidney and Smallintntine From Normal. Nephrectomized. or Smalllnte.tlne-Resected Rata 
T....ted or Not With FK 506 
[lfil' ThymIdIne 
Incorpor.1Jon 
Group No. Treatment (1M, Surgery ICOIIIIrrig DNA, 
1 Vehicle No 2.930 = 650 
2 Vehicle Unilateral nephrectomy 5.012 = 559' 
3 FK506 Unilateral nepnrectomy 4.971 :!: 702' 
4 Vehicle No 13.420 = 16.216 
40% small inteSllne 
5 Vehicle resection 73.711 :!: 17,071' 
40% small intestine 
6 FK506 resection 79.823 = 30,973' 
Note: SurgocaJ procedures haYe baM CIeIcnbed etsewnere." The treatment IpflOwl tne same SCI*M used lor the oamat I\el)8tectomlZed anomals desc:nbed In Fig 2. 
The values reported era ilia means trom 1M! rats: SO. 
'Significantly dill_ trom \I!ymIdIne IfICIII1)OnIbOn in kIdneyS !rom non-openoted 8111111a1s (P < 0.05,. 
tSlgnifocantty cM_ !rom thymidine 1IICOIIIQI'811On In the sma. lnleaDne lrom non-operated animals (P < 0.05). 
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